Trastuzumab without chemotherapy in the adjuvant treatment of breast cancer: Subgroup results from a large observational study

The topic of trastuzumab therapy without chemotherapy in early breast cancer (EBC) has been repeatedly discussed at international consensus meetings, but is compromised by the lack of solid evidence from clinical studies.